Family whole-genome testing for children with newly diagnosed cancer
Part of Cancer, Genetic & congenital clinical trials.
This study offers whole-genome testing (a way to read a person’s DNA) to families after a child is newly diagnosed with cancer. It aims to find inherited changes that may explain why cancer happened and guide future care or monitoring.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child has a new cancer diagnosis
- Your child is age 21 or younger
- You (or your legal guardian) are willing to sign written consent to join
- If your child is 12 or older, they may be asked to join the psychosocial part
- A parent or caregiver is expected to participate in the psychosocial part
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whole genome sequencing (a complete read of your DNA) from children and young people with cancer. It aims to learn more about cancer and how it might be treated.
This study looks for genetic changes that may explain why some people get cancer earlier or more often than expected. It may help identify cancer risk patterns in you and your family, and guide what doctors watch for next.
This study looks at DNA (genetic information) from people and families who may have an inherited risk for cancer. It aims to find new genetic markers that can help explain cancer risk and guide future care.
This study tests a new online way to offer genetic testing and counseling for people concerned about hereditary cancer. It aims to make it easier and faster to access these services from home.
This study looks at whether DNA (from a tumor or related samples) can help identify inherited cancer risk in people who develop cancer at a young age. It may help families learn more about risk factors and guide future screening or prevention.
This trial studies how personalized (tailored) genetic testing can help guide care for children with cancer. It may help match treatment choices to each child’s genetic risk, and it includes optional return of germline (inherited) test results.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.